EUVIMEDEUVIMED entdecken
Crossref

Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus

Yujie Zhao, Yao Liu, Jianjun Deng iD, Chenhui Zhu iD, Xiaoxuan Ma, Min Jiang, Daidi Fan iD

Journal of Agricultural and Food Chemistry · 04.10.2023 · 71 (39) · 14263-14275

DOI: 10.1021/acs.jafc.3c01262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 19.09.2023. Verfasst von Yujie Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi'an, Shaanx…. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Basic Research Program of Shaanxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease with increasing morbidity. Protein tyrosine phosphatase 1B (PTP1B) is a major negative regulator of the insulin signaling cascade and has attracted intensive investigation in the T2DM study. Ginseng is widely used to treat metabolic diseases, while the effects of ginsenoside F4 (F4) on T2DM have remained unknown. Here, we identify F4 as an inhibitor of skeletal muscle insulin resistance. The results showed that F4 significantly improved the hyperglycemic state of db/db mice, alleviated dyslipidemia, and promoted skeletal muscle glucose uptake. This phenomenon was closely related to the inhibition of the PTP1B activity. On the one hand, the inhibition of PTP1B activity by F4 resulted in increased insulin receptor (INSR) and insulin receptor substrate 1 tyrosine phosphorylation and enhanced insulin sensitivity. On the other hand, F4 as a PTP1B inhibitor inhibited the inositol-requiring enzyme 1 (IRE-1)/recombinant TNF receptor associated factor 2 (TRAF2)/c-Jun N-terminal kinase signaling pathway and alleviated skeletal muscle endoplasmic reticulum (ER) stress, thereby reducing IRS-1 serine phosphorylation. Both finally activated the PI3K/AKT signaling pathway and promoted glucose transporter protein 4 translocation to the cell membrane for glucose uptake. Taken together, our experiments demonstrate that F4 activates the insulin signaling pathway by inhibiting the activity of PTP1B while inhibiting the IRE-1/TRAF2/JNK signaling pathway, enhancing insulin sensitivity, and alleviating ER stress in the skeletal muscle of db/db mice. Our results indicate that F4 can be used as a PTP1B inhibitor for the treatment of T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2AnimalsMicePhosphoric Monoester HydrolasesPhosphatidylinositol 3-KinasesTNF Receptor-Associated Factor 2Muscle, SkeletalInsulinPhosphorylationGlucoseProtein Tyrosine Phosphatase, Non-Receptor Type 1Ginsenosides

Stichwörter der Autor:innen

PTP1BT2DMendoplasmic reticulum stressginsenoside F4insulin resistance

Substanzen

Phosphoric Monoester HydrolasesPhosphatidylinositol 3-KinasesTNF Receptor-Associated Factor 2InsulinGlucoseProtein Tyrosine Phosphatase, Non-Receptor Type 1ginsenoside F4Ginsenosides

Autor:innen und Institutionen

  • Shaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi'an, Shaanxi 710069, China.
  • Shaanxi R&D Center of Biomaterials and Fermentation Engineering, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi'an, Shaanxi 710069, China.
  • Biotech. & Biomed. Research Institute, Northwest University, Taibai North Road 229, Xi'an, Shaanxi 710069, China.
  • Shaanxi Institute of Microbiology, Xiying Road 76, Xi'an, Shaanxi 710043, China.
  • State Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211800, China.

ORCID-Profile: Jianjun Deng, Chenhui Zhu, Daidi Fan

Förderung

  • National Key Research and Development Program of China
  • Natural Science Basic Research Program of Shaanxi Province
  • National Natural Science Foundation of China
  • Key Research and Development Projects of Shaanxi Province

Zitieren

APA

Zhao, Y., Liu, Y., Deng, J., Zhu, C., Ma, X., Jiang, M., & Fan, D. (2023). Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus. Journal of Agricultural and Food Chemistry, 71(39), 14263-14275. https://doi.org/10.1021/acs.jafc.3c01262

Vancouver

Zhao Y, Liu Y, Deng J, Zhu C, Ma X, Jiang M, et al. Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus. Journal of Agricultural and Food Chemistry. 2023;71(39):14263-14275. doi:10.1021/acs.jafc.3c01262

BibTeX
@article{Zhao2023,
  author = {Zhao, Yujie and Liu, Yao and Deng, Jianjun and Zhu, Chenhui and Ma, Xiaoxuan and Jiang, Min and Fan, Daidi},
  title = {Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2023},
  volume = {71},
  number = {39},
  pages = {14263--14275},
  doi = {10.1021/acs.jafc.3c01262}
}
Kostenlos starten →